SBIR/STTR Research Award
MICROMATERIAL FABRICATION FOR BIOMOLECULE ANALYSIS
Award amount
$625,950Program and phase
SBIR · Phase IIAward year
2002Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MASS CONSORTIUM CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Technological improvements in biochemical
mass spectrometry have changed the way biomolecules are examined. No longer are
scientists relying solely on gels or other methods that have a high degree of error and a low degree of specificity. Yet even given the broad success of
techniques such as electrospray ionization (ESI) and matrix-assisted laser
desorption/ionization (MALDI) mass spectrometry (MS) there is still significant
potential for improvement to address biochemical problems. A new and promising
strategy for mass spectrometry, laser desorption/ionization from a porous
silicon surface, is a marriage between micromaterial fabrication and
microchemical approaches combined with laser-based desorption ionization
techniques. Desorption/ionization on silicon (DIOS) uses porous silicon to trap
analytes deposited on the surface and UV laser radiation is absorbed by the
silicon surface facilitating vaporization and ionization. Preliminary
experiments with DIOS-MS on biomolecules have allowed for the generation of
intact molecular ions with little or no fragmentation and sensitivity at least
as high as MALDI-MS. The primary goal of the proposed research is to optimize
porous silicon preparation for a large variety of biomolecules, high throughput
applications, and ultimately for the large-scale manufacture of these surfaces.
Given the tremendous growth in mass spectrometry-based applications for
biomolecule analysis, new technology that could further improve on small
molecule analysis and compatibility with microfluidics and silicon microchip
technology as well as impurity tolerance, sensitivity, and automation will have
an enormous impact in the biological sciences.
PROPOSED COMMERCIAL APPLICATION: Given the tremendous growth in mass spectrometry-based applications for biomolecule analysis, new technology, such as desorption ionization on silicon (DIOS), that further improves mass spectrometry's compatibility with microfluidics and silicon microchip technology as well as in impurity tolerance, sensitivity, and automation will have an enormous impact in the pharmaceutical industry and biological sciences.
Technology keywords
Not reported